logo
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
logo
CONTACT US
CALL US
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us
Google Reviews Logo

317.636.6481

One Indiana Square, Suite 1400 Indianapolis, Indiana 46204

Make a Payment
  • Home
  • Firm Overview
  • Our Attorneys
  • Practice Areas
    • Pharmaceutical Drug & Medical Device Litigation
    • Personal Injury
    • Sexual Abuse
    • Class Action
    • Medical Malpractice
    • Eminent Domain
    • Family Law
    • Business Services, Real Estate & Business Litigation
    • Bankruptcy, Creditor’s Rights, & Commercial & Business Law
    • Appellate Law
  • Firm News
    • News & Announcements
    • Alerts
  • Resources
    • Video Library
    • Blog
  • Contact Us

Home » FDA: Yaz Patients at Higher Risk for Blood Clots

FDA: Yaz Patients at Higher Risk for Blood Clots

The FDA met Thursday December 8, 2011 to speak with a panel of experts regarding growing concern that Yaz and other drospirenone-containing drugs increase a patient’s risk of developing blood clots in the lungs and legs. Experts weighed in on this issue and cited 5 large studies that supported the argument that drugs such as Yaz and Yasmin, which contain the manmade hormone drospirenone, do increase the chance of developing dangerous blood clots that could trigger heart attacks, strokes, and blockages in the lungs. In fact, one study by the FDA found that women taking Yasmin had a 75% higher chance of suffering a blood clot when compared to patients taking other older formulations of birth control drugs.

The FDA has not set a deadline for the change in labeling that will advise Yaz patients of the increased risk for blood clots. If you or a loved one has taken Yaz, Yasmin, or another drospirenone-containing birth control pill and has suffered an injury please contact our office today to speak with one of our product liability/personal injury attorneys to discuss your legal options.

One Indiana Square Suite 1400
Indianapolis, Indiana 46204

Copyright ©  Cohen & Malad, LLP. All rights reserved.

Disclaimer  |  Privacy Policy

 

Schedule a free consultation Today
  • This field is for validation purposes and should be left unchanged.

Schedule a free consultation Today

  • This field is for validation purposes and should be left unchanged.

ALERTS

University of Southern California Agrees to $852 Million Settlement in Sexual Abuse Lawsuit

More than 700 women who claim University of Southern California campus gynecologist Dr. George Tyndall sexually abused .. Read More

SEE ALL ALERTS

In the News

Natalie A. Lyons Joins Class Action Practice at Cohen & Malad, LLP Six Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers Rising Stars List Thirteen Cohen & Malad, LLP Attorneys Named to 2021 Indiana Super Lawyers List
READ OUR NEWS